Heckel B (2024) Idiopathic intracranial hypertension after Abrupt Cessation of Medication: a Case Report of Abrupt Glucagon-Like Peptide-1 (GLP-1) receptor Agonist Cessation and Review of the literature
Back DiMarchi, R Efendic, S (1997) 'Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity', US Patent US6191102B1.Back Drucker, DJ, Habener, JF, Holst, JJ (1 Dec 2017) 'Discovery, characterization, and clinical development of the glucagon-like peptides', Journal of Clinical Investigation , 127/12, 4217-27
Distribution : Once in systemic circulation, retatrutide is extensively bound to albumin through its C18 fatty diacid moiety
Return the vial to the refrigerator as soon as possible, and if you have concerns about cumulative thermal exposure, inspect the solution carefully for any visual changes before your next use
Together, these findings provide evidence for the beneficial effects of incretin-based therapies for kidney function in populations without diabetes
The core principles haven't changed from what works with current GLP-1 medications